|
1
|
Reni M, Mazza E, Zanon S, Gatta G and
Vecht CJ: Central nervous system gliomas. Crit Rev Oncol Hematol.
113:213–234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Le Rhun E, Rhun EL, Taillibert S and
Chamberlain MC: The future of high-grade glioma: Where we are and
where are we going. Surg Neurol Int. 6 (Suppl 1):S9–S44. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ostrom QT, Gittleman H, Liao P,
Vecchione-Koval T, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS Statistical Report: Primary brain and other central nervous
system tumors diagnosed in the United States in 2010–2014. Neuro
Oncol. 19 (Suppl_5):v1–v88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ostrom QT, Gittleman H, Truitt G, Boscia
A, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report:
Primary brain and other central nervous system tumors diagnosed in
the United States in 2011–2015. Neuro Oncol. 20 (Suppl_4):iv1–iv86.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han D, Yu T, Dong N, Wang B, Sun F and
Jiang D: Napabucasin, a novel STAT3 inhibitor suppresses
proliferation, invasion and stemness of glioblastoma cells. J Exp
Clin Cancer Res. 38:2892019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ji Y, Sun Q, Zhang J and Hu H: MiR-615
inhibits cell proliferation, migration and invasion by targeting
EGFR in human glioblastoma. Biochem Biophys Res Commun.
499:719–726. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gil-García B and Baladrón V: The complex
role of NOTCH receptors and their ligands in the development of
hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma.
Biol Cell. 108:29–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stockhausen MT, Kristoffersen K and
Poulsen HS: The functional role of Notch signaling in human
gliomas. Neuro Oncol. 12:199–211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lino MM, Merlo A and Boulay JL: Notch
signaling in glioblastoma: A developmental drug target? BMC Med.
8:722010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guichet PO, Guelfi S, Teigell M, Hoppe L,
Bakalara N, Bauchet L, Duffau H, Lamszus K, Rothhut B and Hugnot
JP: Notch1 stimulation induces a vascularization switch with
pericyte-like cell differentiation of glioblastoma stem cells. Stem
Cells. 33:21–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aster JC, Pear WS and Blacklow SC: The
varied roles of Notch in cancer. Annu Rev Pathol. 12:245–275. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohtsuka T, Ishibashi M, Gradwohl G,
Nakanishi S, Guillemot F and Kageyama R: Hes1 and Hes5 as notch
effectors in mammalian neuronal differentiation. EMBO J.
18:2196–2207. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang YM, Chen SX, Dai QF, Jiang ST, Chen
AL, Tang CZ and Zhang YQ: Effect of acupuncture on the notch
signaling pathway in rats with brain injury. Chin J Integr Med.
24:537–544. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Purow BW, Haque RM, Noel MW, Su Q, Burdick
MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, et al:
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1,
is critical for glioma cell survival and proliferation. Cancer Res.
65:2353–2363. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu GW, Wu L, Kuang W, Chen Y, Zhu XG, Guo
H and Lang HL: Knockdown of linc-OIP5 inhibits proliferation and
migration of glioma cells through down-regulation of YAP-NOTCH
signaling pathway. Gene. 610:24–31. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu S, Chen Q, Lin T, Hong W, Wu W, Wu M,
Du X and Jin R: The function of Notch1 intracellular domain in the
differentiation of gastric cancer. Oncol Lett. 15:6171–6178.
2018.PubMed/NCBI
|
|
18
|
Tamura K, Taniguchi Y, Minoguchi S, Sakai
T, Tun T, Furukawa T and Honjo T: Physical interaction between a
novel domain of the receptor Notch and the transcription factor
RBP-J kappa/Su(H). Curr Biol. 5:1416–1423. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu YY, Fu LA, Li SZ, Chen Y, Li JC, Han J,
Liang L, Li L, Ji CC, Zheng MH and Han H: Hif-1α and Hif-2α
differentially regulate Notch signaling through competitive
interaction with the intracellular domain of Notch receptors in
glioma stem cells. Cancer Lett. 349:67–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Renfrow JJ, Soike MH, Debinski W,
Ramkissoon SH, Mott RT, Frenkel MB, Sarkaria JN, Lesser GJ and
Strowd RE: Hypoxia-inducible factor 2α: A novel target in gliomas.
Future Med Chem. 10:2227–2236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Patel SA and Simon MC: Biology of
hypoxia-inducible factor-2alpha in development and disease. Cell
Death Differ. 15:628–634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Chen T, Zhang J, Mao Q, Li S,
Xiong W, Qiu Y, Xie Q and Ge J: Notch1 promotes glioma cell
migration and invasion by stimulating β-catenin and NF-κB signaling
via AKT activation. Cancer Sci. 103:181–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin X, Liu B, Yang X, Yue X, Diao L, Wang
J and Chang J: Genetic deletion of Rnd3 results in aqueductal
stenosis leading to hydrocephalus through up-regulation of Notch
signaling. Proc Natl Acad Sci USA. 110:8236–8241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ronchi CL, Sbiera S, Altieri B, Steinhauer
S, Wild V, Bekteshi M, Kroiss M, Fassnacht M and Allolio B: Notch1
pathway in adrenocortical carcinomas: Correlations with clinical
outcome. Endocr Relat Cancer. 22:531–543. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Elmaci İ, Altinoz MA, Sari R and Bolukbasi
FH: Phosphorylated histone H3 (PHH3) as a novel cell proliferation
marker and prognosticator for meningeal tumors: A short review.
Appl Immunohistochem Mol Morphol. 26:627–631. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang T, Arslanova D, Gu Y, Augelli-Szafran
C and Xia W: Quantification of gamma-secretase modulation
differentiates inhibitor compound selectivity between two
substrates Notch and amyloid precursor protein. Mol Brain.
1:152008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jun HT, Stevens J and Kaplan-Lefko P: Top
NOTCH targets: Notch signaling in cancer. Drug Development
Research. 69:319–328. 2010. View Article : Google Scholar
|
|
29
|
Pancewicz-Wojtkiewicz J: Epidermal growth
factor receptor and notch signaling in non-small-cell lung cancer.
Cancer Med. 5:3572–3578. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng HB, Wang J, Jiang HR, Mei X, Zhao YY,
Chen FR, Qu Y, Sai K, Guo CC, Yang QY, et al: β-elemene selectively
inhibits the proliferation of glioma stem-like cells through the
downregulation of Notch1. Stem Cells Transl Med. 6:830–839. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang BQ, Yang B, Yang HC, Wang JY, Hu S,
Gao YS and Bu XY: MicroRNA-499a decelerates glioma cell
proliferation while accelerating apoptosis through the suppression
of Notch1 and the MAPK signaling pathway. Brain Res Bull.
142:96–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hai L, Zhang C, Li T, Zhou X, Liu B, Li S,
Zhu M, Lin Y, Yu S, Zhang K, et al: Notch1 is a prognostic factor
that is distinctly activated in the classical and proneural subtype
of glioblastoma and that promotes glioma cell survival via the
NF-κB(p65) pathway. Cell Death Dis. 9:1582018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Q, Zheng JM, Chen JK, Yan XL, Chen HM,
Nong WX and Huang HQ: Histone deacetylase 5 promotes the
proliferation of glioma cells by upregulation of Notch 1. Mol Med
Rep. 10:2045–2050. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheung HC, Corley LJ, Fuller GN,
McCutcheon IE and Cote GJ: Polypyrimidine tract binding protein and
Notch1 are independently re-expressed in glioma. Mod Pathol.
19:1034–1041. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Saito N, Fu J, Zheng S, Yao J, Wang S, Liu
DD, Yuan Y, Sulman EP, Lang FF, Colman H, et al: A high Notch
pathway activation predicts response to γ secretase inhibitors in
proneural subtype of glioma tumor-initiating cells. Stem Cells.
32:301–312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu B, Lin X, Yang X, Dong H, Yue X,
Andrade KC, Guo Z, Yang J, Wu L, Zhu X, et al: Downregulation of
RND3/RhoE in glioblastoma patients promotes tumorigenesis through
augmentation of notch transcriptional complex activity. Cancer Med.
4:1404–1416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Wang H, Ge H and Yang Z: AG-1031
induced autophagic cell death and apoptosis in C6 glioma cells
associated with Notch-1 signaling pathway. J Cell Biochem.
119:5893–5903. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xie Q, Mittal S and Berens ME: Targeting
adaptive glioblastoma: An overview of proliferation and invasion.
Neuro Oncol. 16:1575–1584. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Villani V, Mahadevan KK, Ligorio M,
Fernández-Del Castillo C, Ting DT, Sabbatino F, Zhang I, Vangel M,
Ferrone S, Warshaw AL, et al: Phosphorylated histone H3 (PHH3) is a
superior proliferation marker for prognosis of pancreatic
neuroendocrine tumors. Ann Surg Oncol. 23:609–617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Arumugam TV, Cheng YL, Choi Y, Choi YH,
Yang S, Yun YK, Park JS, Yang DK, Thundyil J, Gelderblom M, et al:
Evidence that gamma-secretase-mediated Notch signaling induces
neuronal cell death via the nuclear factor-kappaB-Bcl-2-interacting
mediator of cell death pathway in ischemic stroke. Mol Pharmacol.
80:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li B, Duan P, Han X, Yan W and Xing Y:
NICD inhibits cell proliferation and promotes apoptosis and
autophagy in PC12 cells. Mol Med Rep. 16:2755–2760. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Alexander BM and Cloughesy TF: Adult
glioblastoma. J Clin Oncol. 35:2402–2409. 2017. View Article : Google Scholar : PubMed/NCBI
|
